Enbridge Inc. (ENB) Analysts See $0.46 EPS; Galectin Therapeutics Has 1.29 Sentiment - The Hi New Ulm

#Energy Enbridge Inc. (ENB) Analysts See $0.46 EPS; Galectin Therapeutics Has 1.29 Sentiment  The Hi New Ulm

Galectin Therapeutics Inc (GALT) investors sentiment decreased to 1.29 in Q3 2018. It's down -0.21, from 1.5 in 2018Q2. The ratio dropped, as 27 funds opened ...

http://bit.ly/2GAQbFE http://bit.ly/PowurGuy